Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001343

Drug Information
SynonymsBW A825C; ( E,E )-3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid; Acrivastina; -Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (2; CHEMBL1224; (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid; BIDD:GT0209; C22H24N2O2; Acrivastin; Acrivastine (USAN/INN); BW 825C; E)- (9CI); Acrivastinum; CID5284514; 2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2E)-; (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure; I14-8671; BW 0270C; BW-825C; (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid; AC1NR4LM; AC1Q5T9P; 2-Propenoic acid, 3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (E,E)-; LS-178016; 87848-99-5; UNII-A20F9XAI7W; (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid; AKOS005067182; Acrivastine [USAN:INN:BAN]; Acrivastina [Spanish]; AC-912; D02760; 3-{6-[1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid; 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-; Acrivastinum [Latin]; Semprex; MolPort-005-942-272; ACRIVASTINE    
Trade NameBenadryl Allergy Relief    
CompanyPfizer Pharmaceuticals    
IndicationAllergic rhinitisApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnti-Inflammatory Agents    
CAS NumberCAS 87848-99-5
PubChem Compound IDCID 5284514.    
PubChem Substance IDSID 193142.    
SuperDrug ATC IDR06AX18;    
SuperDrug CAS ID087848995;    
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1Comparative tolerability of second generation antihistamines. Drug Saf. 1999 May;20(5):385-401. To Reference
Ref 2Clinical pharmacology of new histamine H1 receptor antagonists. Clin Pharmacokinet. 1999 May;36(5):329-52. To Reference
Ref 3Nonsedating histamine H1-receptor antagonists. Clin Pharm. 1989 May;8(5):331-44. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543